This week on "The Top Line," we explore our annual special report on the top money raisers in the biotech industry.

Which company raised the most funding in 2023? What does the biotech financing landscape look like for this year? Fierce Biotech's Annalee Armstrong and Max Bayer answer those questions and many more in today's episode. They also discuss the details of the special report and share some of the stories behind the numbers. 

To learn more about the topics in this episode:  
Biotech's top money raisers of 2023
Fierce Biotech Fundraising Tracker 2024
Fierce Biotech Fundraising Tracker 2023

This week on "The Top Line," we explore our annual special report on the top money raisers in the biotech industry.
Which company raised the most funding in 2023? What does the biotech financing landscape look like for this year? Fierce Biotech's Annalee Armstrong and Max Bayer answer those questions and many more in today's episode. They also discuss the details of the special report and share some of the stories behind the numbers. 
To learn more about the topics in this episode:  
<ul>
<li><a href="https://www.fiercebiotech.com/special-reports/biotechs-top-money-raisers-2023" data-cke-saved-href="https://www.fiercebiotech.com/special-reports/biotechs-top-money-raisers-2023">Biotech's top money raisers of 2023</a></li>
<li><a href="https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-24" data-cke-saved-href="https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-24">Fierce Biotech Fundraising Tracker 2024</a></li>
<li><a href="https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-23" data-cke-saved-href="https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-23">Fierce Biotech Fundraising Tracker 2023</a></li>
</ul>

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement